Stocks and Investing Stocks and Investing
Thu, July 21, 2022

Shagun Singh Maintained (ABT) at Buy with Decreased Target to $132 on, Jul 21st, 2022


Published on 2024-10-27 22:05:36 - WOPRAI, Shagun Singh
  Print publication without navigation


Shagun Singh of RBC Capital, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $143 to $132 on, Jul 21st, 2022.

Shagun has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with Shagun's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 9 analyists that currently disagree with Shagun


  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $112 on, Wednesday, July 20th, 2022
  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $126 on, Monday, July 18th, 2022
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $126 on, Monday, July 18th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $117 on, Friday, July 15th, 2022
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $130 on, Wednesday, July 13th, 2022
  • Mike Polark of "Wolfe Research" Initiated at Sell on, Wednesday, July 6th, 2022
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Decreased Target to $130 on, Friday, June 24th, 2022
  • Travis Steed of "B of A Securities" Maintained at Strong Buy and Held Target at $140 on, Tuesday, May 31st, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
Contributing Sources